CIP
OM icon

Champlain Investment Partners’s Outset Medical OM Stock Holding History

Champlain Investment Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-128,436
Closed -$21M – 126
2023
Q3 		$21M Buy
128,436
+124
+0.1% +$29.3K 0.14% 122
2023
Q2 		$42.1M Buy
128,312
+6,524
+5% +$1.99M 0.26% 110
2023
Q1 		$33.6M Sell
121,788
-2,239
-2% -$822K 0.21% 122
2022
Q4 		$48M Sell
124,027
-5,279
-4% -$1.49M 0.31% 111
2022
Q3 		$30.9M Buy
129,306
+17,831
+16% +$4.77M 0.21% 121
2022
Q2 		$24.8M Sell
111,475
-24,971
-18% -$10.7M 0.16% 123
2022
Q1 		$92.9M Buy
136,446
+11,602
+9% +$6.98M 0.48% 83
2021
Q4 		$86.3M Buy
124,844
+412
+0.3% +$305K 0.39% 99
2021
Q3 		$92.3M Buy
124,432
+45,405
+57% +$30.9M 0.44% 95
2021
Q2 		$59.2M Buy
79,027
+40,668
+106% +$31.1M 0.28% 113
2021
Q1 		$31.3M Buy
+38,359
New +$29.6M 0.16% 120

Other funds holding OM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Champlain Investment Partners's OM Position: Q4 2023 in Review

Champlain Investment Partners sold out of Outset Medical (OM) in Q4 2023, closing a stake of 128,436 shares — an estimated $21M sold.

Champlain Investment Partners first reported a position in OM in Q1 2021 and held it in 11 quarters. The position peaked at $92.9M in Q1 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Champlain Investment Partners reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Champlain Investment Partners sold 128,436 Outset Medical shares in Q4 2023, an estimated $21M.
  • Champlain Investment Partners first reported a position in Outset Medical in Q1 2021 and held it in 11 quarters.
  • Champlain Investment Partners's Outset Medical position peaked at $92.9M in Q1 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Champlain Investment Partners's 13F filing for Q4 2023, filed 13 Feb 2024.